Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: A new strategy that might lead to improved activity

Inorganic Chemistry

Volumn 46, Issue 3, 2007, Pages 975-992

  Bratsos, Ioannis ^a   Serli, Barbara ^a   Zangrando, Ennio ^a   Katsaros, Nikos ^b   Alessio, Enzo ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847168976     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic0613964     Document Type: Article

References (79)

1. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drugs; Lippert, B., Ed.; VHCA: Zürich, 1999.
2. Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451-2466.
3. Lebwohl, D.; Canetta, R. Eur. J. Cancer 1998, 34, 1522-1534.
4. (a) Guo, Z.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 1512-1531.
5. (b) Clarke, M. J. Coord. Chem. Rev. 2002, 232, 69-93.
6. (c) Zhang, C. X.; Lippard, S. J. Curr. Opin. Chem. Biol. 2003, 7, 481-489.
7. (a) Clarke, M. J.; Zhu, F.; Frasca, D. R. Chem. Rev. 1999, 99, 2511-2533.
8. (b) Allardyce, C. S.; Dyson, P. J. Platinum Metals Rev. 2001, 45, 62-69.
9. (c) Clarke, M. J. Coord. Chem. Rev. 2003, 236, 209-233.
10. (d) Yan, Y. K.; Melchart, M.; Habtemariam, A.; Sadler, P. J. Chem. Commun. 2005, 4764-4776.
11. (e) Dyson, P. J.; Sava, G. Dalton Trans. 2006, 1929-1933.
12. (a) Sava, G.; Alessio, E.; Bergamo, A.; Mestroni, G. In Topics in Biological Inorganic Chemistry, Volume 1: Metallo-pharmaceuticals; Clarke, M. J., Sadler, P. J., Eds.; Springer: Berlin, 1999; pp 143-169.
13. (b) Alessio, E.; Mestroni, G.; Bergamo, A.; Sava, G. In Metal Ions in Biological Systems, Vol. 42: Metal Ions and Their Complexes in Medication and in Cancer Diagnosis and Therapy; Sigel, A., Sigel, H., Eds.; M. Dekker: New York, 2004; pp 323-351.
14. (c) Alessio, E.; Mestroni, G.; Bergamo, A.; Sava, G. Curr. Topics Med. Chem. 2004, 4, 1525-1535.
15. Redemaker-Lakhai, J. M.; van den Bongard, D.; Pluim, D.; Beijnen, J. H.; Schellens, J. H. M. Clin. Cancer Res. 2004, 10, 3717-3727.
16. Reisner, E.; Arion, V. B.; Guedes da Silva, M. F. C.; Lichtenecker, R.; Eichinger, A.; Keppler, B. K.; Kukushkin, V. Y.; Pombeiro, A. J. L. Inorg. Chem. 2004, 43, 7083-7093 and references therein.
17. Sava, G.; Bergamo, A.; Zorzet, S.; Gava, B.; Casarsa, C.; Cocchietto, M.; Furlani, A.; Scarcia, V.; Serli, B.; Iengo, E.; Alessio, E.; Mestroni, G. Eur. J. Cancer 2002, 38, 427-435.
18. Hotze, A. C. G.; Bacac, M.; Velders, A. H.; Jansen, B. A. J.; Kooijman, H.; Spek, A. L.; Haasnoot, J. G.; Reedijk, J. J. Med. Chem. 2003, 46, 1743-1750.
19. (a) Alessio, E.; Xu, Y.; Cauci, S.; Mestroni, G.; Quadrifoglio, F.; Viglino, P.; Marzilli, L. G. J. Am. Chem. Soc. 1989, 111, 7068-7071.
20. (b) Sava, G.; Pacor, S.; Zorzet, S.; Alessio, E.; Mestroni G. Pharmacol. Res. 1989, 21, 617-628.
21. (c) Sava, G.; Pacor, S.; Bregant, F.; Ceschia, V.; Luxich, E.; Alessio, E.; Mestroni, G. Pharmacol. (Life Sci. Adv.) 1990, 9, 79-84.
22. (d) Loseto, F.; Alessio, E.; Mestroni, G.; Lacidogna, G.; Nassi, A.; Giordano, D.; Coluccia M. Anticancer Res. 1991, 11, 1549-1554.
23. (e) Colucci, M.; Coluccia, M.; Montemurro, P.; Conese, M.; Nassi, A.; Loseto, F.; Alessio, E.; Mestroni, G.; Semeraro N. Int. J. Oncol. 1993, 2, 527-529.
24. (f) Mestroni, G.; Alessio, E.; Sava, G.; Pacor, S.; Coluccia, M. In Metal Complexes in Cancer Chemotherapy; Keppler, B. K., Ed.; VCH Verlag: Weinheim, 1993; pp 159-185.
25. (g) Coluccia, M.; Sava, G.; Loseto, F.; Nassi, A.; Boccarelli, A.; Giordano, D.; Alessio, E.; Mestroni, G. Eur. J. Cancer 1993, 29, 1873-1879.
26. Brindell, M.; Kulis, E.; Elmroth, S. K. C.; Urbanska, K.; Stochel, G. J. Med. Chem. 2005, 48, 7298-7304.
27. Alessio, E. Chem. Rev. 2004, 104, 4203-4242.
28. Buslaeva, T. M.; Rudnitskaya, O. V.; Kabanova, A. G.; Fedorova, G. A. Russ. J. Coord. Chem. 2000, 26, 429-432.
29. Malik, K. Z.; Robinson, S. D.; Steed, J. W. Polyhedron 2000, 19, 1589-1592.
30. Bratsos, I.; Zangrando, E.; Serli, B.; Katsaros, N.; Alessio, E. Dalton Trans. 2005, 3881-3885.
31. Piggot, P. M. T.; Hall, L. A.; White, A. J. P.; Williams, D. J. Inorg. Chim. Acta 2004, 357, 250-258.
32. (a) Rack, J. J.; Rachford, A. A.; Shelker, A. M. Inorg. Chem. 2003, 42, 7357-7359.
33. (b) Rachford, A. A.; Petersen, J. L.; Rack, J. J. Inorg. Chem. 2005, 44, 8065-8075.
34. Davies, D. L.; Fawcett, J.; Krafczyk, R.; Russell, D. R.; Singh, K. J. Chem. Soc., Dalton Trans. 1998, 2349-2352.
35. (a) Khokhar, A. R.; Lumetta, G. J. Inorg. Chim. Acta 1988, 153, 255-259.
36. (b) Cleare, M. J.; Hoeschele, J. D. Bioinorg. Chem. 1973, 2, 187-210.
37. (a) Rao, C. N. R.; Natarajan, S.; Vaidhyanathan, R. Angew. Chem., Int. Ed. 2004, 43, 1466-1496.
38. (b) Perles, J.; Iglesias, M.; Ruiz-Valero, C.; Snejko, N. Chem. Commun. 2003, 346-347 and references therein.
39. Alessio, E.; Mestroni, G.; Nardin, G.; Attia, W. M.; Calligaris, M.; Sava, G.; Zorzet, S. Inorg. Chetn. 1988, 27, 4099-4106.
40. Iengo, E.; Zangrando, E.; Baiutti, E.; Munini, F.; Alessio, E. Eur. J. Inorg. Chem. 2005, 1019-1031.
41. Collaborative Computational Project, No. 4. Acta Crystallogr., Sect. D 1994, 50, 760-763.
42. Otwinowski, Z.; Minor, W. In Processing of X-ray Diffraction Data Collected in Oscillation Mode; Carter, C. W., Jr., Sweet, R. M., Eds.; Methods in Enzymology, Volume 276: Macromolecular Crystallography, Part A; Academic Press: New York, 1997; Vol 276, pp 307-326.
43. Sheldrick, G. M. SHELX97, Programs for Crystal Structure Analysis (Release 97-2); University of Göttingen: Göttingen, Germany, 1998.
44. Farrugia, L. J. J. Appl. Crystallogr. 1999, 32, 837-838.
45. (a) Calligaris, M.; Carugo, O. Coord. Chem. Rev. 1996, 153, 83-154,
46. (b) Calligaris, M. Coord. Chem. Rev. 2004, 248, 351-375.
47. 2O described in this section pertain to fresh solutions exclusively.
48. Barnes, J. R.; Goggin, P. L.; Goodfellow, R. J. J. Chem. Res. 1979, 1610-1656.
49. 2(cbdc), this synthetic procedure led to the dinuclear compound 4.
50. In principle, each complex can exist as two stereoisomers that can be formally interconverted by 180° rotation of the chelating mmal (Supporting Information). For both 9 and 10, only one stereoisomer, presumably the most stable one, was found in the solid state X-ray structures.
51. 2-dmmal)] (12), could be isolated as an intermediate in the synthesis of 11. Similarly to 5, in aqueous solution, compound 12 slowly evolves to the more stable dinuclear species 11.
52. The resonance at δ = 3.42 overlaps with a resonance from 6. This is evident in the HMQC spectrum, in which this singlet has cross-peaks with two well-separated signals in the carbon dimension (Supporting Information).
53. 13C NMR spectrum confirms that the malonate ligand remains coordinated to Ru in 6a since no signals of the free ligand (at δ = 179.7 and 49.5) were observed.
54. (a) Hernández-Molina, M.; Lorenzo-Luis, P. A.; Ruiz-Pérez, C. Cryst. Eng. Comm. 2001, 16, 1-4.
55. (b) Castillo, O.; Luque, A.; Sertucha, J.; Román, P.; Lloret, F. Inorg. Chem. 2000, 39, 6142-6144 and references therein.
56. (a) Ruiz-Pérez, C.; Rodriguez-Marin, Y.; Hernández-Molina, M.; Delgado, F. S.; Pasán, J.; Sanchiz, J.; Lloret, F.; Julve, M. Polyhedron 2003, 22, 2111-2123.
57. (b) Pasán, J.; Delgado, F. S.; Rodriguez-Marin, Y.; Hernández-Molina, M.; Ruiz-Pérez, C.; Sanchiz, J.; Lloret, F.; Julve, M. Polyhedron 2003, 22, 2143-2153.
58. (a) Bianchi, M.; Frediani, P.; Matteoli, U.; Menchi, G.; Piacenti, F.; Petrucci, G. J. Organometal. Chem. 1983, 259, 207-214.
59. (b) Shiu, K.-B.; Lee, H.-C.; Lee, G.-H.; Wang, Y. Organometallics 2002, 21, 4013-4016.
60. (c) Salvini, A.; Frediani, P.; Rivalta, E. Inorg. Chim. Acta 2003, 351, 225-234.
61. Cheng, P.-T.; Loescher, B. R.; Nyburg, S. C. Inorg. Chem. 1971, 10, 1275-1281.
62. Steed, J. W.; Tocher, D. A. Polyhedron 1992, 11, 1849-1854.
63. Yan, H.; Süss-Fink, G.; Neels, A.; Stoeckli-Evans, H. J. Chem. Soc., Dalton Trans. 1997, 4345-4350.
64. Fujino, T.; Hoshino, Y.; Eto, M.; Yukawa, Y.; Fiedler, J.; Kaim, W. Chem. Lett. 2003, 32, 274-275.
65. (a) van Buijtenen, J.; Meuldijk, J.; Vekemans, J. A. J. M.; Hulshof, L. A.; Kooijman, H.; Spek, A. L. Organometallics 2006, 25, 873-881.
66. (b) van Nispen, S. F. G. M.; van Buijtenen, J.; Vekemans, J. A. J. M.; Meuldijk, J.; Hulshof, L. A. Tetrahedron: Asymmetry 2006, 17, 2299-2305.
67. Deng, Y.; Khokhar, A. R. Inorg. Chim. Acta 1993, 204, 35-38.
68. 3,μ-oxalato compounds: (a) Geiser, U.; Ramakrishna, B. L.; Willett, R. D.; Hulsbergen, F. B.; Reedijk, J. Inorg. Chem. 1987, 26, 3750-3756.
69. (b) Oshio, H.; Nagashima, U. Inorg. Chem. 1992, 31, 3295-3301.
70. (c) Rochon, F. D.; Melanson, R.; Andruh, M. Inorg. Chem. 1996, 35, 6086-6092.
71. (d) Shen, H.-Y.; Bu, W.-M.; Liao, D.-Z.; Jiang. Z.-H.; Yan, S.-P.; Wang, G.-L. Inorg. Chem. 2000, 39, 2239-2242.
72. (e) Novosad, J.; Messimeri, A. C.; Papadimitriou, C. D.; Veltsistas, P. G.; Woollins, J. D. Trans. Met. Chem. 2000, 25, 664-669.
73. (f) Ballester, G.; Coronado, E.; Giménez-Saiz, C.; Romero, F. M. Angew. Chem., Int. Ed. 2001, 40, 792-795.
74. 3,μ-oxalato compounds: (a) Kansikas, J.; Pajunen, A. Acta Crystallogr., Sect. B 1980, 36, 2423-2425.
75. (b) Chiozzone, R.; González, R.; Kremer, C.; De Munno, G.; Cano, J.; Lloret, F.; Julve, M.; Faus, J. Inorg. Chem. 1999, 38, 4745-4752.
76. (c) Marinescu, G.; Andruh, M.; Lescouëzec, R.; Muñoz, M. C.; Cano, J.; Lloret, F.; Julve, M. New J. Chem. 2000, 24, 527-536.
77. (d) Chiozzone, R.; González, R.; Kremer, C.; De Munno, G.; Armentano, D.; Cano, J.; Lloret, F.; Julve, M.; Faus, J. Inorg. Chem. 2001, 40, 4242-4249.
78. (e) Costisor, O.; Mereiter, K.; Juive. M.; Lloret, F.; Journaux, Y.; Linert, W.; Andruh, M. Inorg. Chim. Acta 2001, 324, 352-358.
79. f) Núñez, H.; Timor, J.-J.; Server-Carrió, J.; Soto, L.; Escrivà, E. Inorg. Chim. Acta 2001, 318, 8-14.